Showing results (1481-1490 of 1,592) with videos related to

Sort By:
Pageof 160
European Radiology|April 9, 2024
Recurrent medical imaging exposures for the care of patients: one way forwardDonald Paul Frush, Jenia Vassileva, Marco Brambilla, et al.
Head and Neck Pathology|June 17, 2026
Oral Melanoma: A South American Collaborative Series of 21 CasesJosé Alcides Almeida de Arruda, Mariana Villarroel-Dorrego, Claudia Patricia Peña-Vega, et al.
Journal of Medicinal Chemistry|April 14, 2009
8-(4-Methoxyphenyl)pyrazolo[1,5-a]-1,3,5-triazines: selective and centrally active corticotropin-releasing factor receptor-1 (CRF1) antagonistsPaul J Gilligan, Liqi He, Todd Clarke, et al.
Alimentary Pharmacology & Therapeutics|April 17, 2020
Accurate non-invasive diagnosis and staging of non-alcoholic fatty liver disease using the urinary steroid metabolomeAhmad Moolla, Jasper de Boer, David Pavlov, et al.
NPJ Precision Oncology|March 12, 2025
A phase II trial of mTORC1/2 inhibition in STK11 deficient non small cell lung cancerGary Middleton, Helen L Robbins, Peter Fletcher, et al.
The Journal of Clinical Endocrinology and Metabolism|October 9, 2024
Impaired 11β-Hydroxysteroid Dehydrogenase Type 2 Activity in Kidney Disease Disrupts 11-Oxygenated Androgen BiosynthesisMaria Tomkins, Tara McDonnell, Leanne Cussen, et al.
Phytopathology|March 17, 2015
Phenotypic and Genotypic Characterization of Race TKTTF of Puccinia graminis f. sp. tritici that Caused a Wheat Stem Rust Epidemic in Southern Ethiopia in 2013-14Pablo Olivera, Maria Newcomb, Les J Szabo, et al.
ACS Medicinal Chemistry Letters|May 26, 2015
Discovery of a Potent Parenterally Administered Factor XIa Inhibitor with Hydroxyquinolin-2(1H)-one as the P2' MoietyZilun Hu, Pancras C Wong, Paul J Gilligan, et al.
BMJ Open|July 27, 2021
A prospective, phase II, single-centre, cross-sectional, randomised study investigating Dehydroepiandrosterone supplementation and its Profile in Trauma: ADaPTConor Bentley, Claire Potter, Kamal Makram Yakoub, et al.
Journal of Medicinal Chemistry|April 14, 2009
Synthesis and structure-activity relationships of 8-(pyrid-3-yl)pyrazolo[1,5-a]-1,3,5-triazines: potent, orally bioavailable corticotropin releasing factor receptor-1 (CRF1) antagonistsPaul J Gilligan, Todd Clarke, Liqi He, et al.
Pageof 160